Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

NG2 knockdown in GBM xenografts increased vascular reabsorption, decreased plasma volume and normalized tumour vasculature. by Jian Wang (5901)

Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

Endotoxin tolerance is associated with decreased TNFα and increased IL-10, S100A8 and S100A9 mRNA expressions. by Mathieu Fontaine (582183)

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

Downregulation of activin A leads to a decrease in proliferation. by Andreia Bufalino (5664958)

Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

“…We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”

SLAP depletion decreases Cbl phosphorylation. by Julhash U. Kazi (291273)

Ara-C treatment caused a decrease in microglia, NG2+ progenitors, oligodendrocytes, astrocytes and T cells in the spinal cord of SOD1^G93A mice. by Jean-Nicolas Audet (326107)

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

Microglia-conditioned medium decreases NPC viability. by Johanna Mäkelä (223358)

TWEAK decreases the mitochondrial membrane potential of keratinocytes. by Sanaa Sabour Alaoui (329300)

MCM-BP can decrease phosphorylation by DDK but is not a substrate. by Tin Nguyen (231591)

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

Decreased osteoclast formation by LDH-A or LDH-B depletion. by Heejin Ahn (3173670)

(R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

(R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

(R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)